GLP-1 weight loss injections, made for women.
A once-weekly injection that helps regulate appetite and metabolism — prescribed, shipped, and supported by a clinical team that actually understands a woman's body.
- ✓No insurance required
- ✓Free expedited delivery
- ✓Unlimited 24/7 support
- ✓HSA / FSA eligible
Stylized for marketing purposes only; image does not reflect the actual label or size of prescription vial. Compounded products are not FDA-approved.
What is a GLP-1?
A hormone your body already makes — amplified.
Glucagon-like peptide-1 (GLP-1) is a natural hormone released after you eat. It signals fullness, slows digestion, and helps your body manage blood sugar. GLP-1 medications mimic that signal — so you feel satisfied sooner, longer, and with less of the constant food noise.
For women, that matters in a particular way. Hormonal shifts through your cycle, postpartum, perimenopause, and menopause can quietly rewrite how your body stores and releases fat. GLP-1 therapy gives you a steady, biological reset.
How GLP-1 works
Four shifts, one weekly dose.
Slows digestion
Food empties from your stomach more gradually, so you feel full for longer.
Quiets appetite
Acts on the brain's hunger centers, calming cravings and reducing food noise.
Stabilizes blood sugar
Improves insulin response so glucose stays steadier between meals.
Supports fat loss
Combined with nutrition and movement, drives sustainable weight loss.
The medications
Prescribed only if it's right for you.
A Renovia clinician will review your health history and goals before prescribing the medication and dose that fits your body best.
Once weekly · GLP-1
Semaglutide
A proven, well-studied GLP-1 receptor agonist. Gentle to start, with a dose schedule designed to minimize side effects.
- Targets the GLP-1 receptor
- Weekly subcutaneous injection
- Average 15% body-weight loss at 68 weeks
Once weekly · GLP-1 + GIP
Tirzepatide
A dual-action option that targets both GLP-1 and GIP receptors. Often prescribed for women seeking greater metabolic support.
- Dual GLP-1 + GIP receptor action
- Weekly subcutaneous injection
- Average 20%+ body-weight loss at 72 weeks
Compounded semaglutide and tirzepatide are not FDA-approved and have not undergone the same clinical studies as commercially available products. They may be legally prescribed by a licensed healthcare provider based on your medical consultation.
Why women choose GLP-1
Renewal you can feel — beyond the scale.
Less food noise
Cravings quiet down so eating becomes a decision, not a fight.
Steady energy
Stabler blood sugar means fewer crashes through the day.
Sustainable loss
Gradual, biology-led results — not a crash diet.
Hormone-aware care
Protocols built around cycle, perimenopause, and postpartum.
Lower cardiometabolic risk
Improvements in blood pressure, cholesterol, and A1C.
Confidence that lasts
Habits, coaching, and a clinical team that doesn't disappear.
Getting started
From quiz to first dose in days.
Health quiz
A 5-minute medical intake covering your goals, hormones, and history.
Clinician review
A licensed provider reviews your file and prescribes only if it's the right fit.
Medication shipped
Discreet, climate-controlled delivery — free, with refills handled for you.
Ongoing support
Message your team anytime. Dose changes, nutrition, side-effect care included.
Honest pricing
One flat price.
Same at every dose.
Medication, clinician visits, and unlimited messaging — all included. No insurance required. HSA and FSA eligible.
Plan
Per Month
Prescription contingent on clinician evaluation. Pricing for compounded GLP-1.
GLP-1, answered
Common questions.
- Will I gain the weight back if I stop?
- Some weight regain is common after stopping any weight-loss treatment. Renovia builds a taper and maintenance plan — focused on nutrition, strength, and habits — so the results last beyond the medication.
- What side effects should I expect?
- Most are mild and temporary: nausea, fatigue, constipation, or appetite changes in the first few weeks. Your clinician will start low and titrate slowly to keep you comfortable.
- How fast will I lose weight?
- Most patients see 1–2 lbs per week once on a therapeutic dose. Over 6–12 months, average loss is 15–20% of body weight, but results vary.
- Do I have to inject myself?
- Yes — it's a once-weekly subcutaneous injection (stomach, thigh, or upper arm). The needle is tiny, and your care team walks you through your first dose.
- Is GLP-1 safe for women planning pregnancy?
- GLP-1 medications should not be used during pregnancy. You'll need to stop at least 2 months before trying to conceive. Talk with your Renovia clinician about timing.
- Can I use HSA or FSA?
- Yes. Renovia is HSA and FSA eligible. We don't bill insurance — pricing stays flat and predictable.
Important safety information
What you should know before starting.
Semaglutide and tirzepatide are GLP-1 receptor agonists used for chronic weight management alongside a reduced-calorie diet and increased physical activity, in adults with a BMI of 30+ (obesity), or 27+ with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.
Do not use if you or a family member has had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you've had a serious allergic reaction to semaglutide or tirzepatide.
Serious side effects may include thyroid tumors, pancreatitis, gallbladder problems, kidney injury, severe gastrointestinal symptoms, low blood sugar (especially with diabetes medications), changes in vision, increased heart rate, and serious allergic reactions. Stop the medication and contact a provider for severe abdominal pain, persistent vomiting, or symptoms of an allergic reaction.
Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, bloating, and heartburn.
GLP-1 medications should not be used during pregnancy or breastfeeding. Tell your clinician about all medications, supplements, and conditions you have.
Compounded medications are not FDA-approved and do not undergo the same clinical studies as commercially available products. Report side effects to FDA MedWatch at 1-800-FDA-1088 or fda.gov/medwatch. For emergencies, call 911. This is not a complete list of risks — discuss all questions with your healthcare provider.
Ready when you are
Find out if GLP-1 is right for you.
Take the 5-minute quiz. A licensed clinician reviews every applicant.